Facebook Linkedin RSS Twitter Youtube
Home 2022

Healthcare financing

Into Orbit: Satellite Bio Raises $110M toward Tissue Therapeutics
GEN Edge

Into Orbit: Satellite Bio Raises $110M toward Tissue Therapeutics

Resilience Raises $625M Series D Financing toward Expanded Biomanufacturing Services
Bioprocessing

Resilience Raises $625M Series D Financing toward Expanded Biomanufacturing Services

Waters Eyes M&A, ‘Market-Plus’ Growth after Strong Q1
Bioprocessing

Waters Eyes M&A, ‘Market-Plus’ Growth after Strong Q1

Kriya Raises $270M Series C toward Fully Integrated Gene Therapy Engine
Cancer

Kriya Raises $270M Series C toward Fully Integrated Gene Therapy Engine

StockWatch: Biohaven, and Investors, Benefit from Pfizer Buying Spree
Cancer

StockWatch: Biohaven, and Investors, Benefit from Pfizer Buying Spree

Pfizer Adds Migraine Drugs with Planned $11.6B Biohaven Acquisition
Drug Discovery

Pfizer Adds Migraine Drugs with Planned $11.6B Biohaven Acquisition

StockWatch: Investors Unfazed by Biogen CEO Search, Aduhelm Cutbacks
Cancer

StockWatch: Investors Unfazed by Biogen CEO Search, Aduhelm Cutbacks

Third Phase: Synthego Expanding Cell, Gene Therapy Capabilities with $200M Financing
GEN Edge

Third Phase: Synthego Expanding Cell, Gene Therapy Capabilities with $200M Financing

Biden Cancer Moonshot Target: 50% Lower Death Rate in 25 Years
Cancer

Biden Cancer Moonshot Target: 50% Lower Death Rate in 25 Years

Pardes Biosciences Advances Oral Antiviral Drug for SARS-CoV-2 Infections
Coronavirus

Pardes Biosciences Advances Oral Antiviral Drug for SARS-CoV-2 Infections

1...456...22Page 5 of 22
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.